
    
      Patients were enrolled according to the standard design of the Phase I study. Anlotinib are
      divided into 3 dosage levels, including 8mg, 10mg, 12mg; Oral administration of anlotinib was
      given, qd, D1-D14; taken on an empty stomach, Every 3 weeks is a cycle, a total of 2 cycles;
      Starting from the first level of anlotinib, the dose will be ramped up in sequence.
    
  